4/A//SEC Filing
Gormally John J 4/A
Accession 0001493152-18-005018
CIK 0001321834other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 8:42 PM ET
Size
5.0 KB
Accession
0001493152-18-005018
Insider Transaction Report
Form 4/AAmended
Gormally John J
Chief Executive Officer
Transactions
- Award
Common Stock
2017-10-17$0.88/sh+150,000$132,000→ 180,000 total
Footnotes (1)
- [F1]On October 17, 2017, the Board of Directors of Akers Biosciences, Inc. approved the issuance of 150,000 restricted shares of common stock to the reporting person pursuant to the Akers Biosciences, Inc. 2017 Equity Incentive Plan.
Documents
Issuer
Akers Biosciences, Inc.
CIK 0001321834
Entity typeother
Related Parties
1- filerCIK 0001661118
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 8:42 PM ET
- Size
- 5.0 KB